Profile data is unavailable for this security.
About the company
Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.
- Revenue in SEK (TTM)1.30m
- Net income in SEK-27.16m
- Incorporated2012
- Employees11.00
- LocationFluicell ABFlojelbergsgatan 8CMOELNDAL 431 37SwedenSWE
- Phone+46 313607481
- Websitehttps://fluicell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lidds AB | 0.00 | -25.60m | 18.97m | 1.00 | -- | 2.46 | -- | -- | -0.4664 | -0.4664 | 0.00 | 0.0566 | 0.00 | -- | -- | 0.00 | -97.07 | -46.33 | -111.99 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.1044 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
Circio Holding ASA | 119.40k | 9.23m | 19.47m | 8.00 | 1.20 | -- | 1.95 | 163.07 | 0.6836 | 0.6836 | 0.0156 | -4.05 | 0.0043 | -- | 0.0145 | 11,181.82 | 33.11 | -46.58 | -- | -53.40 | -- | -- | 7,730.08 | -6,902.00 | -- | -- | -- | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
Stayble Therapeutics AB | 0.00 | -20.40m | 28.64m | 2.00 | -- | 2.34 | -- | -- | -0.6413 | -0.6413 | 0.00 | 0.2795 | 0.00 | -- | -- | 0.00 | -81.91 | -78.64 | -93.24 | -95.58 | -- | -- | -- | -- | -- | -- | 0.065 | -- | -- | -- | 3.22 | -- | -- | -- |
SoftOx Solutions AS | 1.61m | -58.81m | 33.34m | 7.00 | -- | 0.2297 | -- | 20.69 | -0.7729 | -0.7729 | 0.0022 | 0.0766 | 0.0166 | -- | 0.493 | 237,141.40 | -60.65 | -50.11 | -81.43 | -63.61 | -- | -- | -3,649.40 | -639.34 | 0.4049 | -2.76 | 0.1463 | -- | -1.88 | 10.06 | 44.55 | -- | 39.43 | -- |
Scandion Oncology A/S | 0.00 | -54.53m | 33.86m | 4.00 | -- | 0.725 | -- | -- | -0.3727 | -0.3727 | 0.00 | 0.2014 | 0.00 | -- | -- | 0.00 | -72.35 | -- | -84.88 | -- | -- | -- | -- | -- | -- | -- | 0.0058 | -- | -- | -- | 48.89 | -- | -- | -- |
ATTANA AB | 5.14m | -12.18m | 35.31m | 10.00 | -- | 2.18 | -- | 6.87 | -0.0361 | -0.0361 | 0.0148 | 0.0376 | 0.1715 | -0.4127 | 1.97 | 514,073.00 | -40.63 | -37.18 | -62.57 | -46.66 | 127.26 | 175.97 | -236.92 | -254.69 | 0.4858 | -4.43 | 0.158 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
Peptonic Medical AB | 39.05m | -45.25m | 35.68m | 37.00 | -- | 0.1917 | -- | 0.9138 | -0.025 | -0.025 | 0.0222 | 0.0323 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
Fluicell AB | 1.30m | -27.16m | 37.36m | 11.00 | -- | 1.73 | -- | 28.81 | -0.1493 | -0.1493 | 0.0055 | 0.045 | 0.0525 | 0.5265 | 1.98 | 76,294.12 | -109.94 | -87.55 | -141.87 | -126.02 | -17.66 | 72.97 | -2,094.37 | -650.23 | 3.83 | -695.51 | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
Double Bond Phrmcutcl Intrntnl AB (publ) | 1.20m | -16.75m | 37.57m | 10.00 | -- | 10.10 | -- | 31.30 | -0.18 | -0.18 | 0.0125 | 0.0351 | 0.0949 | -- | 21.10 | 120,004.00 | -132.48 | -80.90 | -176.94 | -106.45 | -344.65 | -1,073.66 | -1,395.47 | -1,360.03 | 1.12 | -1.36 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
Respiratorius AB (publ) | 1.35m | -7.30m | 37.63m | -- | -- | 0.9465 | -- | 27.94 | -0.0229 | -0.0229 | 0.0042 | 0.078 | 0.0461 | -- | -- | -- | -24.98 | -- | -26.52 | -- | 63.66 | -- | -542.36 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -9.55 | -- |
Orphazyme A/S | 0.00 | -17.38m | 47.69m | 1.00 | -- | 1.95 | -- | -- | -325.75 | -325.75 | 0.00 | 455.65 | 0.00 | -- | -- | 0.00 | -42.26 | -76.08 | -50.77 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
Combigene AB | 1.91m | -36.52m | 49.90m | 10.00 | -- | 0.5269 | -- | 26.07 | -1.84 | -1.84 | 0.0967 | 4.78 | 0.0161 | -- | 3.71 | 239,265.00 | -30.66 | -13.00 | -32.33 | -14.58 | -- | -- | -1,908.16 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
Nidhogg Resources Holding AB (publ) | 32.00k | -4.21m | 54.09m | 3.00 | -- | 59.38 | -- | 1,690.42 | -0.0021 | -0.0021 | 0.00005 | 0.0005 | 0.0087 | -- | 0.0128 | 10,666.67 | -114.92 | -70.56 | -204.32 | -82.81 | -25,093.75 | -- | -13,156.25 | -- | -- | -- | -- | -- | -- | -- | 77.06 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Fluicell AB's reporting currency: Swedish Krona SEK
Holder | Shares | % Held |
---|---|---|
FCG Fonder ABas of 30 Aug 2024 | 71.26k | 0.02% |
Data from 30 Aug 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.